301 related articles for article (PubMed ID: 17462604)
21. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.
Whitley AC; Sweet DH; Walle T
Drug Metab Dispos; 2005 Aug; 33(8):1097-100. PubMed ID: 15870380
[TBL] [Abstract][Full Text] [Related]
22. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
[TBL] [Abstract][Full Text] [Related]
23. Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate.
Uwai Y; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(2):163-9. PubMed ID: 20460822
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of pemetrexed transport by renal basolateral organic anion transporter hOAT3.
Kurata T; Iwamoto T; Kawahara Y; Okuda M
Drug Metab Pharmacokinet; 2014; 29(2):148-53. PubMed ID: 24042472
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Hamada Y; Ikemura K; Iwamoto T; Okuda M
Pharmacology; 2018; 101(3-4):176-183. PubMed ID: 29353278
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans.
Nakagomi-Hagihara R; Nakai D; Tokui T
Xenobiotica; 2007 Apr; 37(4):416-26. PubMed ID: 17455113
[TBL] [Abstract][Full Text] [Related]
27. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
28. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
29. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
[TBL] [Abstract][Full Text] [Related]
31. Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.
Watanabe H; Sakaguchi Y; Sugimoto R; Kaneko K; Iwata H; Kotani S; Nakajima M; Ishima Y; Otagiri M; Maruyama T
Clin Exp Nephrol; 2014 Oct; 18(5):814-20. PubMed ID: 24185403
[TBL] [Abstract][Full Text] [Related]
32. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
33. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
[TBL] [Abstract][Full Text] [Related]
35. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
37. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
38. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
39. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Taniguchi R; Motohashi H; Saito H; Okuda M; Inui K
Drug Metab Pharmacokinet; 2004 Oct; 19(5):369-74. PubMed ID: 15548848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]